LOS ANGELES, CA, Microbiome company launched with funding from BOLD Capital, 8VC, Founders Fund, Collaborative Fund, Greycroft, The Chernin Group, Box Group, and Cross Culture Ventures. Read More
CAMBRIDGE, MA, Leader in the emerging field of artificial intelligence (AI)-powered life sciences, today announced the completion of an $11 million Series A financing. Read More
GAITHERSBURG, MD, Leading biopharmaceutical company in development of RNAi therapeutics, announces today that it has closed Series C1 financing. Read More